Last Updated on: 23rd September 2024, 12:49 pm
Dylan, a five-year-old boy from Indonesia, embarked on a transformative journey in July 2024 at Beike Biotech’s partner facility in China, where he underwent a 14-day stem cell treatment. During his stay, Dylan received a total of eight stem cell packs, comprising both mesenchymal stem cells derived from the umbilical cord and blood. In total, he was administered 340 million stem cells via intravenous and intrathecal methods.
Before Treatment:
Before undergoing stem cell therapy at Beike, Dylan exhibited several challenges associated with autism spectrum disorder. His communication skills were notably delayed, characterized by minimal verbal expression, repetitive and irrelevant speech, and a lack of engagement with others, including his seven-year-old sister. Dylan’s behavior was highly routine and inflexible, with a strong preference for repetitive actions. Despite improvements with applied behavioral analysis (ABA) therapy and other interventions, he still displayed signs such as an autistic smile and occasional laughing without apparent reason. His behavior included no aggression or self-harming tendencies, no hyperactivity except slight excitement, and no gastrointestinal issues. Hand flapping had ceased, though occasional hand stimming or fingering persisted. He also had no hyper-sensory responses to sound or smell.
Discovery of Stem Cell Therapy:
Dylan’s family first learned about stem cell therapy through internet research and YouTube videos. They were impressed by the technology and its evidence of potential benefits. Their trust in stem cell therapy led them to consider it as a viable treatment option.
Choosing Beike:
The decision to choose Beike Biotech was influenced by online research, including patient testimonials found on YouTube and the internet. The family was particularly interested in seeing how stem cell therapy had benefited other patients with autism spectrum disorder.
Expectations and Arrival:
Before traveling to Shenzhen, Dylan’s family hoped for significant improvements in his condition, anticipating that the stem cell treatment would enhance his recovery and overall well-being. Upon arrival, they found the facility to be very convenient and comfortable, setting a positive tone for their treatment experience.
Experience with Beike:
The initial days of Dylan’s treatment went smoothly and without complication. His family was notably impressed by the professionalism and warmth exhibited by the Beike staff. The staff’s expertise and compassionate care created a reassuring environment during the treatment period.
Beike’s comprehensive approach, which involved administering a substantial quantity of stem cells, was particularly well-received. The advanced protocols and meticulous care ensured that Dylan received the full benefit of the therapy. This approach not only met but exceeded the family’s expectations, contributing to their overall positive experience with the treatment.
Results & Observations:
Additional Thoughts:
Dylan’s family observed that their son was more composed, with a better grasp of language and longer verbal expressions. They believe that these changes are just the beginning and are hopeful for continued progress in the future.